by Truveta staff | May 17, 2023 | News
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously announced pioneers Pfizer, Boston Scientific Corporation, and Alpine Immune Sciences. We...
by Truveta staff | May 5, 2023 | Technology
Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in clinical practice and the related outcomes. Understanding clinical outcomes or adverse events...
by Truveta staff | Dec 2, 2022 | Culture
At Truveta, we love chatting to our employees about their work, goals, and interests. Next in our series highlighting our MDs, we spoke to Raj Brar, a director of clinical informatics at Truveta. He joined the team in August 2022. How did you get into medicine? I...
by Truveta Research | Oct 31, 2022 | Research, Research Insights
On February 17, 2022, Abbott voluntarily recalled powdered formula made in a Michigan facility due to complaints of Cronobacter sakazakii and Salmonella Newport contamination [1]. Datasembly reported that baby formula was out-of-stock at 31% of stores in April 2022...
by Truveta staff | Sep 19, 2022 | Culture
At Truveta, we give our team members the opportunity to share their stories and add a human perspective to the work we do every day. We often share awareness and prevention days to encourage everyone to remember that there are names and faces behind so much of the...
